why choose us

First received: July 06, 2022

Clinical Trial: A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Migraine

Study Type: INTERVENTIONAL


Official Title: Interventional, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of add-on Eptinezumab Treatment to Brief Educational Intervention for the Preventive Treatment of Migraine in Patient

Brief Summary: Medication overuse headache (MOH) is a type of headache caused by excessive use of acute headache or migraine medications (medications used to treat a headache or migraine once it begins).Treatment of MOH usually involves reducing the dose of or discontinuing acute medications.Eptinezumab is a medication used for the preventive treatment of migraine in adults.The main goals of this trial are to learn whether eptinezumab helps reduce the number of days with migraine, the number of days with headache, and acute…

Read more